Ionis Pharmaceuticals, Inc.
Hedge Funds Holdings
Last updated:
Ionis Pharmaceuticals, Inc.‘s stocks are currently a part of 305 hedge funds’ portfolios, which represents 80.85% of the total amount of its stocks outstanding. This makes up a total of 114.64M shares of Ionis Pharmaceuticals, Inc.. Compared to the previous quarter, the number fell by -6.34% or -7.76M shares fewer. As for the holding position changes, 29.18% (89) of current hedge fund investors increased the number of shares held, 38.36% (117) of current holders sold a part of the shares held, and 15.74% (48) closed the holdings completely. 48 hedge funds are new holders of Ionis Pharmaceuticals, Inc. stock in Q3 2022, it is 15.74% of total holders.
Hedge funds holding Ionis Pharmaceuticals (Q4 2017 – Q3 2022)
| Q4 2017 | 310 |
|---|---|
| Q1 2018 | 321 |
| Q2 2018 | 301 |
| Q3 2018 | 316 |
| Q4 2018 | 322 |
| Q1 2019 | 386 |
| Q2 2019 | 387 |
| Q3 2019 | 361 |
| Q4 2019 | 376 |
| Q1 2020 | 351 |
| Q2 2020 | 363 |
| Q3 2020 | 353 |
| Q4 2020 | 367 |
| Q1 2021 | 350 |
| Q2 2021 | 325 |
| Q3 2021 | 310 |
| Q4 2021 | 324 |
| Q1 2022 | 315 |
| Q2 2022 | 334 |
| Q3 2022 | 305 |
Hedge funds changes in Ionis Pharmaceuticals positions (Q4 2017 – Q3 2022)
| Q4 2017 | 54 | 87 | 114 | 39 | 16 |
|---|---|---|---|---|---|
| Q1 2018 | 52 | 113 | 102 | 36 | 18 |
| Q2 2018 | 30 | 109 | 93 | 49 | 20 |
| Q3 2018 | 49 | 84 | 114 | 33 | 36 |
| Q4 2018 | 48 | 90 | 116 | 43 | 25 |
| Q1 2019 | 94 | 106 | 126 | 28 | 32 |
| Q2 2019 | 65 | 165 | 95 | 57 | 5 |
| Q3 2019 | 40 | 126 | 117 | 67 | 11 |
| Q4 2019 | 64 | 114 | 130 | 43 | 25 |
| Q1 2020 | 36 | 106 | 135 | 59 | 15 |
| Q2 2020 | 49 | 121 | 131 | 33 | 29 |
| Q3 2020 | 42 | 111 | 129 | 52 | 19 |
| Q4 2020 | 65 | 119 | 113 | 48 | 22 |
| Q1 2021 | 53 | 126 | 107 | 65 | -1 |
| Q2 2021 | 52 | 111 | 100 | 74 | -12 |
| Q3 2021 | 35 | 105 | 100 | 49 | 21 |
| Q4 2021 | 56 | 106 | 115 | 38 | 9 |
| Q1 2022 | 48 | 106 | 106 | 51 | 4 |
| Q2 2022 | 53 | 90 | 126 | 32 | 33 |
| Q3 2022 | 48 | 89 | 117 | 48 | 3 |
Hedge funds changes in Ionis Pharmaceuticals stock options (Q4 2017 – Q3 2022)
| Q4 2017 | 60,896,000 | 73,478,000 |
|---|---|---|
| Q1 2018 | 44,945,000 | 41,987,000 |
| Q2 2018 | 45,148,000 | 56,878,000 |
| Q3 2018 | 77,456,000 | 98,032,000 |
| Q4 2018 | 64,175,000 | 112,159,000 |
| Q1 2019 | 108,959,000 | 222,597,000 |
| Q2 2019 | 81,271,000 | 119,291,000 |
| Q3 2019 | 94,632,000 | 97,440,000 |
| Q4 2019 | 89,033,000 | 102,902,000 |
| Q1 2020 | 30,899,000 | 46,538,024 |
| Q2 2020 | 42,713,000 | 48,693,088 |
| Q3 2020 | 32,498,000 | 36,554,450 |
| Q4 2020 | 88,367,000 | 35,034,000 |
| Q1 2021 | 56,277,000 | 32,514,000 |
| Q2 2021 | 48,630,000 | 35,585,000 |
| Q3 2021 | 34,527,000 | 28,006,184 |
| Q4 2021 | 14,932,000 | 26,394,866 |
| Q1 2022 | 11,427,000 | 18,743,000 |
| Q2 2022 | 22,553,000 | 8,880,000 |
| Q3 2022 | 21,537,000 | 9,645,000 |